Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Sense of coherence in people with and without inflammatory bowel diseases - is there a difference?

Naftali T, Eindor-Abarbanel A, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Laish I, Matalon S, Shirin H, Milgrom Y, Ziv-Baran T, Broide E.

J Gastrointestin Liver Dis. 2019 Mar;28(1):29-32. doi: 10.15403/jgld.2014.1121.281.coh.

2.

Diabetes Mellitus and Age are Risk Factors of Interval Colon Cancer: A Case-Control Study.

Laish I, Mizrahi J, Naftali T, Konikoff FM.

Dig Dis. 2019;37(4):291-296. doi: 10.1159/000496740. Epub 2019 Feb 7.

PMID:
30731459
3.

The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel.

Naftali T, Eindor-Abarbanel A, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Konikoff F, Matalon S, Shirin H, Milgrom Y, Ziv-Baran T, Broide E.

Can J Gastroenterol Hepatol. 2018 Sep 9;2018:5090849. doi: 10.1155/2018/5090849. eCollection 2018.

4.

Risk of metachronous advanced lesions after resection of diminutive and small, non-advanced adenomas.

Laish I, Sergeev I, Stein A, Naftali T, Konikoff FM.

Clin Res Hepatol Gastroenterol. 2019 Apr;43(2):201-207. doi: 10.1016/j.clinre.2018.03.001. Epub 2018 Sep 25.

PMID:
30266580
5.

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.

Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Dig Liver Dis. 2019 Jan;51(1):68-74. doi: 10.1016/j.dld.2018.07.040. Epub 2018 Aug 10.

PMID:
30172649
6.

Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study.

Ungar B, Engel T, Yablecovitch D, Lahat A, Lang A, Avidan B, Har-Noy O, Carter D, Levhar N, Selinger L, Neuman S, Natour OH, Yavzori M, Fudim E, Picard O, Kopylov U, Chowers Y, Naftali T, Broide E, Shachar E, Eliakim R, Ben-Horin S.

Am J Gastroenterol. 2018 Jun;113(6):890-898. doi: 10.1038/s41395-018-0073-0. Epub 2018 Jun 5.

PMID:
29867175
7.

Revealing the Puzzle of Nonadherence in IBD-Assembling the Pieces.

Eindor-Abarbanel A, Naftali T, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Konikoff F, Matalon S, Shirin H, Milgrom Y, Broide E.

Inflamm Bowel Dis. 2018 May 18;24(6):1352-1360. doi: 10.1093/ibd/izy013.

PMID:
29718228
8.

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, Magro F, Biron AI, Lopez-Serrano P, Casanova MJ, Gompertz M, Vitor S, Arroyo M, Pugliese D, Zabana Y, Vicente R, Aguas M, Shitrit BA, Gutierrez A, Doherty GA, Fernandez-Salazar L, Cadilla MJ, Huguet JM, OʼToole A, Stasi E, Marcos MN, Villoria A, Karmiris K, Rahier JF, Rodriguez C, Palomares DM, Fiorino G, Benitez JM, Principi M, Naftali T, Taxonera C, Mantzaris G, Sebkova L, Iade B, Lissner D, Bradley FI, Roman LA, Marin-Jimenez I, Merino O, Sierra M, Van Domselaar M, Caprioli F, Guerra I, Peixe P, Piqueras M, Rodriguez-Lago I, Ber Y, van Hoeve K, Torres P, Gravito-Soares M, Rudbeck-Resdal D, Bartolo O, Peixoto A, Martin G, Armuzzi A, Garre A, Donday MG, de Carpi MFJ, Gisbert JP.

Am J Gastroenterol. 2018 Mar;113(3):396-403. doi: 10.1038/ajg.2017.501. Epub 2018 Feb 20.

PMID:
29460920
9.

Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.

Nallathambi R, Mazuz M, Ion A, Selvaraj G, Weininger S, Fridlender M, Nasser A, Sagee O, Kumari P, Nemichenizer D, Mendelovitz M, Firstein N, Hanin O, Konikoff F, Kapulnik Y, Naftali T, Koltai H.

Cannabis Cannabinoid Res. 2017 Jul 1;2(1):167-182. doi: 10.1089/can.2017.0027. eCollection 2017.

10.

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.

Lahat A, Shitrit AB, Naftali T, Milgrom Y, Elyakim R, Goldin E, Levhar N, Selinger L, Zuker T, Fudim E, Picard O, Yavzori M, Ben-Horin S.

J Crohns Colitis. 2018 Jan 5;12(1):120-123. doi: 10.1093/ecco-jcc/jjx120.

PMID:
28961712
11.

Surveillance after positive colonoscopy based on adenoma characteristics.

Laish I, Seregeev I, Naftali T, Konikoff FM.

Dig Liver Dis. 2017 Oct;49(10):1115-1120. doi: 10.1016/j.dld.2017.05.005. Epub 2017 May 16.

PMID:
28641945
12.

Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization?

Naftali T, Konikoff FM.

Isr Med Assoc J. 2017 Feb;19(2):95-97. No abstract available.

13.

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Naftali T, Mechulam R, Marii A, Gabay G, Stein A, Bronshtain M, Laish I, Benjaminov F, Konikoff FM.

Dig Dis Sci. 2017 Jun;62(6):1615-1620. doi: 10.1007/s10620-017-4540-z. Epub 2017 Mar 27.

PMID:
28349233
14.

Low prevalence of dysplastic polyps in patients with ulcerative colitis.

Laish I, Shurani A, Barkay O, Konikoff FM, Naftali T.

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):204-209. doi: 10.1016/j.clinre.2016.09.009. Epub 2016 Nov 9.

PMID:
27838112
15.

[MEDICAL CANNABIS].

Naftali T.

Harefuah. 2016 Feb;155(2):79-82, 133. Hebrew.

PMID:
27215115
16.

Reply.

Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, Gophna U.

Inflamm Bowel Dis. 2016 May;22(5):E15-6. doi: 10.1097/MIB.0000000000000782. No abstract available.

PMID:
27096566
17.

Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome.

Niv E, Halak A, Tiommny E, Yanai H, Strul H, Naftali T, Vaisman N.

Nutr Metab (Lond). 2016 Feb 6;13:10. doi: 10.1186/s12986-016-0070-5. eCollection 2016.

18.

Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.

Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, Gophna U.

Inflamm Bowel Dis. 2016 Feb;22(2):293-302. doi: 10.1097/MIB.0000000000000662.

PMID:
26752462
19.

Interactions between the intestinal microbiota and bile acids in gallstones patients.

Keren N, Konikoff FM, Paitan Y, Gabay G, Reshef L, Naftali T, Gophna U.

Environ Microbiol Rep. 2015 Dec;7(6):874-80. doi: 10.1111/1758-2229.12319. Epub 2015 Aug 7.

PMID:
26149537
20.

Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel disease.

Laish I, Katz H, Stein A, Liberman M, Naftali T, Kitay-Cohen Y, Biron-Shental T, Konikoff FM, Amiel A.

Dig Liver Dis. 2015 Sep;47(9):790-6. doi: 10.1016/j.dld.2015.05.002. Epub 2015 May 13.

PMID:
26048252

Supplemental Content

Loading ...
Support Center